Health care workers push for their own confidential mental health treatment

States are redefining when medical professionals can get mental health treatment without risking notifying the boards that regulate their licenses.

BeiGene secures accelerated FDA approval for follicular lymphoma treatment – Pharmaceutical Technology

Share this article Follicular lymphoma is the second most common type of non-Hodgkin lymphoma, with approximately 15,000 cases in the US each year. Image credit:

March 8, 2024

Europe’s battle against Aedes mosquitoes: growing threat of mosquito-borne diseases

Study described how cases of all types of mosquito-borne diseases are increasing in Europe.

June 26, 2023

EC upgrades approval for J&J’s Rybrevant/chemotherapy combination in NSCLC – Pharmaceutical Technology

Rybrevant with chemotherapy is the first treatment to offer prolonged progression-free survival for EGFR-mutated non-small cell lung cancer (NSCLC) patients for whom prior therapy has

August 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.